Phenaglycodol
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.001.124 |
| Chemical and physical data | |
| Formula | C11H15ClO2 |
| Molar mass | 214.69 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phenaglycodol (brand names Acalmid, Acalo, Alterton, Atadiol, Felixyn, Neotran, Pausital, Remin, Sedapsin, Sinforil, Stesil, Ultran)[2] is a drug described as a tranquilizer or sedative which has anxiolytic and anticonvulsant properties.[3][4] It is related pharmacologically to meprobamate, though it is not a carbamate.[5][6]
Synthesis
[edit]p-Chloroacetophenone and potassium cyanide (KCN) are reacted together via a Strecker reaction to give the corresponding cyanohydrin (3). The cyano group is then hydrated in acid to the corresponding amide, p-chloroatrolactamide (4). The amide group is then further hydrolyzed with a second equivalent of water in concentrated lye to give p-chloroatrolactic acid (5). Esterification then provides ethyl p-chloroatrolactate (6). Finally, nucleophilic addition with methylmagnesium iodide give phenaglycodol (7) crystals.[7][8]
In a second method, a mixed pinacol coupling reaction between para-chloroacetophenone and acetone that was catalyzed by magnesium activated with a small amount of trimethylsilyl chloride gave a 40% yield of phenglycodol.[9]
See also
[edit]References
[edit]- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Usdin E, Efron DH, U.S. National Institute of Mental Health (1972). Psychotropic drugs and related compounds. National Institute of Mental Health; [for sale by the Supt. of Docs., U.S. Govt. Print. Off., Washington. ISBN 9780080255101.
- ^ Vida J (19 July 2013). Anticonvulsants. Elsevier. pp. 578–. ISBN 978-0-323-14395-0.
- ^ Haddad LM, Winchester JF (1983). Clinical Management of Poisoning and Drug Overdose. Saunders. ISBN 978-0-7216-4447-9.
- ^ Drill VA (1958). Pharmacology in Medicine: A Collaborative Textbook. McGraw-Hill.
- ^ Beckman H (1961). Pharmacology; the nature, action and use of drugs. Saunders.
- ^ US 2812363, Mills J, "2-Chlorophenyl-3-methyl-2,3-butanediols", issued 5 November 1957, assigned to Eli Lilly Co.
- ^ GB 788896, Mills J, "Improvements in or relating to novel substituted butanediol", published 1958-01-08, assigned to Eli Lilly & Co.
- ^ Maekawa H, Yamamoto Y, Shimada H, Yonemura K, Nishiguchi I (2004). "Mg-promoted mixed pinacol coupling". Tetrahedron Letters. 45 (20): 3869–3872. doi:10.1016/j.tetlet.2004.03.109.
Further reading
[edit]- US 3134819, Maxwell G, Pachter IJ, "Novel trifluoromethyl derivatives of substituted diols", issued 26 May 1964, assigned to Smith Kline and French Laboratories Ltd
- Murphy HW (March 1964). "Pinacol Rearrangement of Phenaglycodol I. Characterization of Products Produced". Journal of Pharmaceutical Sciences. 53: 298–301. doi:10.1002/jps.2600530311. PMID 14185017.